Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Revenue (2024 - 2026)

Carlsmed filings provide 2 years of Revenue readings, the most recent being $15.2 million for Q4 2025.

  • On a quarterly basis, Revenue rose 61.19% to $15.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.7 million, a N/A change, with the full-year FY2025 number at $50.5 million, up 85.94% from a year prior.
  • Revenue hit $15.2 million in Q4 2025 for Carlsmed, up from $13.1 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $15.2 million in Q4 2025 to a low of $6.1 million in Q2 2024.